Description
RADIOPHARMACEUTICALS FOR VISN 10
First action · last action
2011-04-04 · 2011-09-30
Transactions
2
First transaction's obligation
$106,533
Base + all options value (sum of deltas)
$105,365
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
5
SDVOSB flag on record
No
Parent IDV
VA250P0650
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2011-04-04+$106,533= $106,533
- Mod P000012011-09-30-$1,168= $105,365
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2011-04-04 | +$106,533 | $106,533 | RADIOPHARMACEUTICALS FOR VISN 10 |
| Mod P00001· FUNDING ONLY ACTION | 2011-09-30 | −$1,168 | $105,365 | RADIOPHARMACEUTICALS FOR VISN 10 |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI MF41LR58N9F7)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| VA25012F0662 | 757-COLUMBUS · 6505 · DRUGS AND BIOLOGICALS | $13,906 | FY2012 |
| VA25012F0576 | 757-COLUMBUS · 6505 · DRUGS AND BIOLOGICALS | $8,857 | FY2012 |
| VA25012P0592 | 552-DAYTON · 6505 · DRUGS AND BIOLOGICALS | $2,194 | FY2012 |
| VA25012F0488 | 757-COLUMBUS · 6505 · DRUGS AND BIOLOGICALS | $9,267 | FY2012 |
| VA25012J0461 | 757-COLUMBUS · 6505 · DRUGS AND BIOLOGICALS | $10,448 | FY2012 |
| VA25012F0482 | 552-DAYTON · 6505 · DRUGS AND BIOLOGICALS | $3,074 | FY2012 |
Other recipients under 6505 from 539-CINCINNATI (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25016J0130 | SCHAAF DRUGS, LLC | 539-CINCINNATI | $600,000 | FY2016 |
| VA25015F0449 | CSL BEHRING L.L.C. | 539-CINCINNATI | $24,062 | FY2015 |
| VA25013D0039 | CINCINNATI UNIV OF | 539-CINCINNATI | $999,524 | FY2013 |
| VA25013F0466 | CSL BEHRING L.L.C. | 539-CINCINNATI | $42,276 | FY2013 |
| VA25013P0365 | GAMBRO RENAL PRODUCTS, INC. | 539-CINCINNATI | $7,554 | FY2013 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA539A10424_3600_VA250P0650_3600 · retrieved 2026-09-26.